The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.
Alan AbdullaT M J EwoldtN G M HunfeldA E MullerW J R RietdijkS PolinderT van GelderH EndemanB C P KochPublished in: BMC infectious diseases (2020)
EudraCT number: 2017-004677-14. Sponsor protocol name: DOLPHIN. Registered 6 March 2018 . Protocol Version 6, Protocol date: 27 November 2019.